[go: up one dir, main page]

AR004668A1 - Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h. - Google Patents

Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h.

Info

Publication number
AR004668A1
AR004668A1 ARP960103094A AR10309496A AR004668A1 AR 004668 A1 AR004668 A1 AR 004668A1 AR P960103094 A ARP960103094 A AR P960103094A AR 10309496 A AR10309496 A AR 10309496A AR 004668 A1 AR004668 A1 AR 004668A1
Authority
AR
Argentina
Prior art keywords
vector
purified
composition
nucleic acid
cell
Prior art date
Application number
ARP960103094A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AR004668A1 publication Critical patent/AR004668A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describe un ácido nucleico aislado purificado, un vector de expresión recombinante que lo comprende, una célula que comprende dicho vector, un métodopara la producción de un polipéptido de H.pylori, una composición de vacuna, el uso de dicha composición para preparar medicamentos, un polipéptido purificadode H.pylori y un método para la detección de la presencia de un ácido nucleico de H.pylori.
ARP960103094A 1995-06-07 1996-07-06 Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h. AR004668A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48703295A 1995-06-07 1995-06-07
US56146995A 1995-11-17 1995-11-17
US63040596A 1996-04-01 1996-04-01

Publications (1)

Publication Number Publication Date
AR004668A1 true AR004668A1 (es) 1999-03-10

Family

ID=27413750

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103094A AR004668A1 (es) 1995-06-07 1996-07-06 Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h.

Country Status (4)

Country Link
AR (1) AR004668A1 (es)
NO (1) NO975745L (es)
SK (1) SK165197A3 (es)
WO (1) WO1996040893A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JPH08509873A (ja) 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US6762295B2 (en) * 1995-04-21 2004-07-13 Csl Limited Protective helicobacter antigens
DE69737413T2 (de) 1996-01-04 2007-10-31 Novartis Vaccines and Diagnostics, Inc., Emeryville Bakterioferritin aus helicobacter pylori
US5780278A (en) * 1996-05-20 1998-07-14 Vanderbilt University IceA gene and related methods
CA2271774A1 (en) * 1996-11-14 1998-05-22 Merieux Oravax Helicobacter polypeptides and corresponding polynucleotide molecules
US6570004B1 (en) * 1996-12-23 2003-05-27 Vanderbilt University dapE gene on Helicobacter pylori and dapE− mutant strains of Helicobacter pylori
AU6583398A (en) * 1997-03-26 1998-10-20 Avant Immunotherapeutics, Inc. Polypeptides which immunoreact with polyclonal antisera against (h. pylori)
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
WO1998043479A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
CA2288211A1 (en) * 1997-04-25 1998-11-05 Genelabs Technologies, Inc. Antigenic composition and method of detection for helicobacter pylori
HUP0003388A3 (en) * 1997-04-30 2001-06-28 Merieux Oravax Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
EP1042001B1 (en) * 1997-12-16 2002-04-03 Chiron Corporation Use of microparticles combined with submicron oil-in-water emulsions
US7393630B2 (en) 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
JPH11221079A (ja) * 1998-02-04 1999-08-17 Kyowa Hakko Kogyo Co Ltd 糖転移酵素および該酵素をコードするｄｎａ
GB9808423D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
EP2261338A3 (en) * 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
US6190667B1 (en) 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
US6222026B1 (en) 1998-09-08 2001-04-24 Smithkline Beecham Corporation Gcp
SE9901548D0 (sv) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
WO2001000796A2 (en) * 1999-06-28 2001-01-04 National Research Council Of Canada Glycosyltransferases of helicobacter pylori
US6861516B1 (en) 1999-10-04 2005-03-01 Merck & Co., Inc. MraY gene and enzyme of pseudomonas aeruginosa
WO2001025251A1 (en) * 1999-10-04 2001-04-12 Merck & Co., Inc. Mray gene and enzyme of pseudomonas aeruginosa
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
AU2001268885A1 (en) * 2000-06-28 2002-01-08 National Research Council Of Canada Helicobacter dd-heptosyltransferase
US7731980B2 (en) 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US6846650B2 (en) * 2000-10-25 2005-01-25 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
CA2589460A1 (en) 2004-11-24 2006-06-01 Theraptosis S.A. New peptides useful as dual caspase-2/-6 inhibitors and their biological applications
EP2837939A1 (en) * 2013-08-13 2015-02-18 Technische Universität München Method for the detection of H.pylori infection

Also Published As

Publication number Publication date
NO975745D0 (no) 1997-12-05
NO975745L (no) 1998-02-09
WO1996040893A1 (en) 1996-12-19
SK165197A3 (en) 1999-01-11

Similar Documents

Publication Publication Date Title
AR004668A1 (es) Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h.
ES2056817T3 (es) Transformacion de trichoderma.
AR020048A1 (es) Un polipeptido dependiente de la vitamina k, una composicion farmaceutica que lo comprende, el uso del mismo para la manufactura de un medicamento, unacido nucleico aislado que codifica a dicho polipeptido y una celula hospedante de mamifero.
SE7705432L (sv) Polypeptid och sett for dess framstellning
ES2187527T3 (es) Estructura de orden superior y enlace de acidos nucleicos peptidicos.
ES2146646T3 (es) Sistema de expresion que permite producir una apoliproteina ai-m.
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
NL193616B (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
ES2114539T3 (es) Expresion de polipeptidos recombinados con purificacion mejorada.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
ATE171216T1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES8306797A1 (es) Un metodo para producir un polipeptido.
ES2009906A6 (es) Procedimiento de preparacion de transformantes bacterianos.
ES444558A1 (es) Procedimiento para la produccion de una preparacion estable de insulina.
FI854227L (fi) Menetelmä analgeettisena aineena käyttökelpoisten polypeptidien valmistamiseksi
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
ES2063113T3 (es) Polipeptidos de veneno de vibora y expresion genetica.
AR009600A1 (es) Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
AR013618A1 (es) Metodo y composiciones para la distribucion y expresion de acidos nucleicos de interferon
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
AU583388B2 (en) High performance liquid chromatography mobile phase
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler

Legal Events

Date Code Title Description
FA Abandonment or withdrawal